share_log

Susquehanna Maintains Negative on RXO, Lowers Price Target to $13

Benzinga ·  Mar 26 12:39

Susquehanna analyst Bascome Majors maintains RXO (NYSE:RXO) with a Negative and lowers the price target from $18 to $13.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 242

Recommended

Write a comment